1. L K, Ng TKS, Wee HN, Ching J. Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations. Mech Ageing Dev. 2023; 211: 111787. [DOI:10.1016/j.mad.2023.111787]

2. Abdolmaleki A, Tamjid M, Hamidi Bagehjan Z, Goodarzifard G, Zohreh R, Asadi A. Neurotransmitters: Types and Molecular Mechanisms of Secretion. The Neuroscience Journal of Shefaye Khatam. 2024. [DOI:10.61186/shefa.12.2.114]

3. Shirian S, Tahmasebian N, Bakhtiari Moghadm B, Kiani FZ, Amini MR. Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2024; 12(3): 103-16. [DOI:10.61186/shefa.12.3.103]

4. Fekete M, Lehoczki A, Major D, Fazekas-Pongor V, Csípő T, Tarantini S, et al. Exploring the Influence of Gut-Brain Axis Modulation on Cognitive Health: A Comprehensive Review of Prebiotics, Probiotics, and Symbiotics. Nutrients. 2024; 16(6). [DOI:10.3390/nu16060789]

5. Zhu F, Li C, Chu F, Tian X, Zhu J. Target dysbiosis of gut microbes as a future therapeutic manipulation in Alzheimer's disease. Frontiers in aging neuroscience. 2020; 12: 544235. [DOI:10.3389/fnagi.2020.544235]

6. Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut microbiome alterations in Alzheimer's disease. Scientific reports. 2017; 7(1): 13537. [DOI:10.1038/s41598-017-13601-y]

7. Grishin A, Papillon S, Bell B, Wang J, Ford HR. The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2013; 22(2): 69-75. [DOI:10.1053/j.sempedsurg.2013.01.002]

8. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews neuroscience. 2012; 13(10): 701-12. [DOI:10.1038/nrn3346]

9. Yaghoubi F, Jafarian M, Gorji A. The Anticonvulsant Effect of the Ketogenic Diet in the Treatment of Epilepsy. The Neuroscience Journal of Shefaye Khatam. 2020; 9(1): 200-9. [DOI:10.52547/shefa.9.1.200]

10. Mazrooei Rad E. Alzheimer's Disease Diagnosis Using Brain Signals and Artificial Neural Networks. The Neuroscience Journal of Shefaye Khatam. 2023; 11(3): 68-80. [DOI:10.61186/shefa.11.3.68]

11. Edalatmanesh MA. A Review of the Breast Milk Properties with Emphasis on the Neuroprotective Potential of Human Breast-Derived Stem Cells. The Neuroscience Journal of Shefaye Khatam. 2021; 9(2): 140-50. [DOI:10.52547/shefa.9.2.140]

12. Gao J, Zhao L, Cheng Y, Lei W, Wang Y, Liu X, et al. Probiotics for the treatment of depression and its comorbidities: A systemic review. Front Cell Infect Microbiol. 2023; 17; 13: 1167116. [DOI:10.3389/fcimb.2023.1167116]

13. Babakhani S, Hosseini F. Gut microbiota: An effective factor in the Human brain and behavior. The Neuroscience Journal of Shefaye Khatam. 2019; 7(1): 106-18. [DOI:10.29252/shefa.7.1.106]

14. Jiang C, Li G, Huang P, Liu Z, Zhao B. The Gut Microbiota and Alzheimer's Disease. J Alzheimers Dis. 2017; 58(1): 1-15. [DOI:10.3233/JAD-161141]

15. Amer M, Nadeem M, Nazir SUR, Fakhar M, Abid F, Ain QU, Asif E. Probiotics and Their Use in Inflammatory Bowel Disease. Altern Ther Health Med. 2018; 24(3): 16-23.

16. Caprara G. Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs). Nutrients. 2021; 13(2). [DOI:10.3390/nu13020429]

17. Shahverdi M, Sourani Z, Sargolzaie M, Modarres Mousavi M, Shirian S. An Investigation into the Effects of Water-and Fat-Soluble Vitamins in Alzheimer's and Parkinson's Diseases. The Neuroscience Journal of Shefaye Khatam. 2023; 11(3): 95-109. [DOI:10.61186/shefa.11.3.95]

18. Shirian S, Tahmasebian N, Bakhtiari Moghadm B, Kiani FZ, Amini MR. Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2024; 12(3): 103-16. [DOI:10.61186/shefa.12.3.103]

19. Shahverdi Shahraki M, Sourani Z, Behdarvand F, Modarres Mousavi M, Shirian S. The Potency of Biomarkers for the Diagnosis and Treatment of Parkinson's disease and Alzheimer's disease. The Neuroscience Journal of Shefaye Khatam. 2022; 10(2): 91-103. [DOI:10.61186/shefa.10.2.91]

20. Reddy DS, Abeygunaratne HN. Experimental and clinical biomarkers for progressive evaluation of neuropathology and therapeutic interventions for acute and chronic neurological disorders. International Journal of Molecular Sciences. 2022; 23(19): 11734. [DOI:10.3390/ijms231911734]

21. Coradduzza D, Sedda S, Cruciani S, De Miglio MR, Ventura C, Nivoli A, Maioli M. Age-Related Cognitive Decline, Focus on Microbiome: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2023; 24(18). [DOI:10.3390/ijms241813680]

22. He J, Wu J, Liu J, Wu H, Hua H. Cognitive impairment and the gut-brain axis during 2014-2023: a bibliometric analysis. 2024; 15. [DOI:10.3389/fneur.2024.1407956]

23. Ullah H, Arbab S, Tian Y, Liu C-q, Chen Y, Qijie L, et al. The gut microbiota-brain axis in neurological disorder. 2023; 17. [DOI:10.3389/fnins.2023.1225875]

24. Zhang R, Ding N, Feng X, Liao W. The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis. 2025; 16. [DOI:10.3389/fimmu.2025.1529958]

25. Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal transduction and targeted therapy. 2024; 9(1): 37. [DOI:10.1038/s41392-024-01743-1]

26. Suganya K, Koo BS. Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. International Journal of Molecular Sciences. 2020; 21(20). [DOI:10.3390/ijms21207551]